Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Ginkgo Leaf Tablets for Vascular Dementia (Phase II)
CTR20140563Phase 2Completed
- Sponsor
- Fangsheng Pharmaceutical
- Start
- Aug 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of compound ginkgo biloba extract in vascular dementia, sponsored by Fangsheng Pharmaceutical. Started Aug 2014; status: completed.
02
Drugs
compound ginkgo biloba extract
03
Conditions
vascular dementia
Beyond the preview
Go deeper on CTR20140563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140563.